These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 818020)

  • 1. Comparison of progenitor toxins of nonproteolytic with those of proteolytic Clostridium botulinum Type B.
    Miyazaki S; Kozaki S; Sakaguchi S; Sakaguchi G
    Infect Immun; 1976 Mar; 13(3):987-9. PubMed ID: 818020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of type B and E Botulinum toxins to purified sulfhydryl-dependent protease produced by Clostridium botulinum type F.
    Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1977 Aug; 30(4):179-90. PubMed ID: 20527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Patterns in the formation of proteolytic enzymes by different strains of C1. botulinum type F].
    Egorova EN; Ispolatovskaia MV; Levdikova GA; Chulkova IF
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Apr; (4):125-9. PubMed ID: 325959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responses of Clostridium botulinum type B and E progenitor toxins to some clostridial sulfhydryl-dependent proteases.
    Oishi I; Okada T; Sakaguchi G
    Jpn J Med Sci Biol; 1975 Jun; 28(3):157-64. PubMed ID: 1104932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular construction of Clostridium botulinum type A toxins.
    Sugii S; Sakaguchi G
    Infect Immun; 1975 Dec; 12(6):1262-70. PubMed ID: 54335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the botulinum neurotoxin type F gene clusters in proteolytic and nonproteolytic Clostridium botulinum and Clostridium barati.
    East AK; Bhandari M; Hielm S; Collins MD
    Curr Microbiol; 1998 Oct; 37(4):262-8. PubMed ID: 9732534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of toxins of Clostridium butyricum and Clostridium botulinum type E.
    Giménez JA; Sugiyama H
    Infect Immun; 1988 Apr; 56(4):926-9. PubMed ID: 3126148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and some properties of progenitor toxins of Clostridium botulinum type B.
    Kozaki S; Sakaguchi S; Sakaguchi G
    Infect Immun; 1974 Oct; 10(4):750-6. PubMed ID: 4214781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clostridium botulinum type D toxin: purification, molecular structure, and some immunological properties.
    Miyazaki S; Iwasaki M; Sakaguchi G
    Infect Immun; 1977 Aug; 17(2):395-401. PubMed ID: 892912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Clostridium botulinum type B toxin by an endogenous enzyme.
    DasGupta BR
    J Bacteriol; 1971 Dec; 108(3):1051-7. PubMed ID: 4945183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Clostridium botulinum, Clostridium argentinense, and related organisms by cellular fatty acid analysis.
    Ghanem FM; Ridpath AC; Moore WE; Moore LV
    J Clin Microbiol; 1991 Jun; 29(6):1114-24. PubMed ID: 1864927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic relationships among the proteolytic and nonproteolytic strains of Clostridium botulinum.
    Solomon HM; Lynt RK; Kautter DA; Lilly T
    Appl Microbiol; 1971 Feb; 21(2):295-9. PubMed ID: 4927406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic mutants obtained from Clostridium botulinum type E.
    Nakane A; Iida H
    Appl Environ Microbiol; 1977 Jul; 34(1):99-101. PubMed ID: 329766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of a protease in natural activation of Clostridium botulinum neurotoxin.
    Das Gupta BR; Sugiyama H
    Infect Immun; 1972 Oct; 6(4):587-90. PubMed ID: 4564288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of the clusters of genes encoding the botulinum neurotoxin complex in clostridium botulinum (Clostridium argentinense) type G and nonproteolytic Clostridium botulinum type B.
    Bhandari M; Campbell KD; Collins MD; East AK
    Curr Microbiol; 1997 Oct; 35(4):207-14. PubMed ID: 9290060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive inhibition between different Clostridium botulinum types and strains.
    Eklund MW; Poysky FT; Peterson ME; Paranjpye RN; Pelroy GA
    J Food Prot; 2004 Dec; 67(12):2682-7. PubMed ID: 15633672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral toxicities of Clostridium botulinum type A and B toxins from different strains.
    Ohishi I
    Infect Immun; 1984 Feb; 43(2):487-90. PubMed ID: 6693168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Clostridium botulinum type A, B, E and F 12S toxins.
    Kozaki S; Sugii S; Oishi I; Sakaguchi S; Sakaguchi G
    Jpn J Med Sci Biol; 1975 Feb; 28(1):70-2. PubMed ID: 1099283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.